AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588307. A total of 62 filers reported holding AVEO PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.16 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $4,124 | -99.8% | 275,892 | +2.8% | 0.00% | – |
| Q3 2022 | $2,208,000 | +18.6% | 268,314 | -5.5% | 0.00% | – |
| Q2 2022 | $1,862,000 | +24.1% | 283,969 | +5.7% | 0.00% | – |
| Q1 2022 | $1,501,000 | +23.5% | 268,684 | +3.7% | 0.00% | – |
| Q4 2021 | $1,215,000 | -21.3% | 259,065 | +3.6% | 0.00% | – |
| Q3 2021 | $1,544,000 | -4.6% | 249,969 | +1.8% | 0.00% | – |
| Q2 2021 | $1,618,000 | -44.4% | 245,645 | -38.3% | 0.00% | – |
| Q1 2021 | $2,912,000 | +57.4% | 397,937 | +24.1% | 0.00% | – |
| Q4 2020 | $1,850,000 | +12.2% | 320,675 | +15.4% | 0.00% | – |
| Q3 2020 | $1,649,000 | +64.2% | 277,771 | +42.4% | 0.00% | – |
| Q2 2020 | $1,004,000 | +184.4% | 195,026 | +99.8% | 0.00% | – |
| Q1 2020 | $353,000 | – | 97,599 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEA Management Company, LLC | 3,952,958 | $23,481,000 | 0.99% |
| Cormorant Asset Management, LP | 1,000,000 | $5,940,000 | 0.23% |
| WealthTrust Axiom LLC | 22,347 | $132,000 | 0.06% |
| SECTORAL ASSET MANAGEMENT INC | 100,000 | $594,000 | 0.05% |
| Virtu Financial LLC | 24,577 | $146,000 | 0.02% |
| PDT Partners, LLC | 61,839 | $367,000 | 0.02% |
| SABBY MANAGEMENT, LLC | 26,039 | $155,000 | 0.02% |
| MGO ONE SEVEN LLC | 10,000 | $59,000 | 0.01% |
| WINTON GROUP Ltd | 45,208 | $269,000 | 0.01% |
| Ancora Advisors LLC | 36,350 | $216,000 | 0.01% |